Learn more about our World Congress 2023 program topic, Managing Ovarian Masses, via our educational resources including lecture videos, UOG articles, VISUOG chapters and learning modules.
Get insight from Prof. Dirk Timmerman and Prof. Tom Bourne discussing the management of ovarian masses at World Congress 2022.
Congress program sessions
Pre-Congress Course: Ovarian masses and endometriosis
Date: 15th October 2023 Time: 09:00 - 17:00
Including presentations on:
- IOTA terms and definitions – how should you describe anadnexal mass?
- The IOTA two step strategy and the IOTA/ESGO/ESGEconsensus approach to classifying masses
- The imaging in gynaecology series: using pattern recognition to identify to typical features of the less common types of ovarian pathology
- Classifying ovarian masses and other pathology in Children and Adolescents
Workshop: Managing ovarian masses – learning how you classify and manage them using case-based examples
- What is the IOTA ADNEX model: how well does it perform, and what features are needed to use it?
- What does IOTA now recommend in daily clinical practice? – The IOTA two step approach, clinical guidelines and linking this to ORADS
- Ultrasound and borderline ovarian tumours – from expectant management to guidance during surgery
- Case examples:
- Using the IOTA two step strategy
- What are the characteristic features of some less well-known masses – the imaging in gynaecology series
- Including evaluating ovarian cysts in pregnancy and young women
Oral communication: Managing ovarian masses
Supplement your learning
Prof. Lil Valentin discusses the detection and recognition of endometriomas, including scans of typical and atypical endometriomas on ultrasound.
Basic Training resources
- Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and OâÂÂÂÂÂÂÂÂRADS in differentiating between benign and malignant adnexal lesions in North American women
- Imaging in gynecological disease: clinical and ultrasound characteristics of ovarian mature cystic teratomas
- Reaffirming microcystic ultrasound appearance of borderline ovarian tumors using three-dimensional ‘silhouette’ rendering
- Imaging in gynecological disease (22): clinical and ultrasound characteristics of ovarian embryonal carcinomas, non-gestational choriocarcinomas and malignant mixed germ cell tumors
Borderline ovarian tumor (BOT)
Borderline ovarian tumors (BOTs) are epithelial tumors with low grade of malignancy. BOTs account for 10–15% of epithelial ovarian tumors. These tumors occur in younger women, with almost 30% of patients younger than 40 years, and are often diagnosed at an earlier stage than invasive carcinomas.
Brenner tumors are surface epithelial–stromal tumors of the ovary, which were first described in detail by Fritz Brenner in 1907. Brenner tumors represent 3.2 % of all ovarian tumors. About 99% of them are benign and most patients are postmenopausal. Brenner tumors are usually unilateral.
Endometrioid carcinoma represents 10-15% of ovarian epithelial carcinomas. In 15-20% of cases endometrial carcinoma is diagnosed at the same time. Tumors are solid or cystic with a mass protruding into the lumen. The most common microscopic pattern is characterised by a confluent glandular epithelial proliferation.
Granulosa cells tumor
A granulosa cell tumor is a rare malignancy with a low malignant potential and therefore it has a relatively good prognosis. Due the intratumoral estrogen production it can cause endometrial pathology and abnormal bleeding as the first presenting symptom. On ultrasound they present as large unilateral solid.
Malignant struma ovarii
Struma ovarii is a rare form of ovarian mature teratoma that contains mostly thyroid tissue. Malignant transformation is uncommon, only about 5% of struma ovarii being malignant. The variable sonographic features of struma ovarii and its rare occurrence makes the sonographic diagnosis very challenging.
Metastases to the ovary
The ovary is a common site of metastases from malignant tumors. Most metastases in the ovaries originate in the gastrointestinal tract or the breast. The distinction between primary and metastatic ovarian neoplasm is of critical importance, since surgical cytoreduction is the treatment of choice for the former.
Dysgerminomas are malignant ovarian germ-cell tumors. Malignant germ-cell tumors of the ovary occur in young women, 75% being diagnosed in the second and third decades of life. At macroscopic evaluation, ovarian dysgerminomas are characteristically solid and well-encapsulated with an average diameter of 15 cm.
Ovarian fibroma and fibrothecoma
Ovarian fibromas and fibrothecomas are benign stromal tumors. They account for approximately 4-6% of all ovarian pathology and occur both in pre- and in postmenopausal women, with their malign counterpart being less than 1%. Ovarian fibromas and fibrothecomas are solid masses, usually unilateral.
Earn CME points as you learn by searching and completing the following activities on the ISUOG Academy learning management system:
CME Activity: Masterclass: Evaluating Metastatic Disease in Ovarian Cancer and Tumor Extension in Endometrial and Cervical Disease
CME Activity: The Role of Modern Imaging Techniques in the Assessment of a Gynecological Cancer Patient: Do we have an Ideal Imaging Technique?
CME Activity: Using Ultrasound to Help Manage Oncology Patients
CME Activity: The Role of New Ultrasound Techniques in the Assessment of Gyne-oncology Patients
Some ISUOG educational resources and lectures require you to become a member. Become a journal member today to have full online access to all articles from Ultrasound in Obstetrics and Gynecology. If you are a member, please sign in to view the locked content.